好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

HIV-associated Myositis and Response to Immune Therapy
Neuromuscular and Clinical Neurophysiology (EMG)
P3 - Poster Session 3 (5:30 PM-6:30 PM)
12-007
To document HIV-associated myopathy response to immune therapy

Inflammatory muscle disease is more common in HIV-infected patients. Inflammatory myopathies associated with HIV may have features overlapping inclusion body myositis (IBM) and polymyositis (PM). Response to immune therapy has been reported in cases of HIV-associated IBM, which is less commonly seen in sporadic IBM (sIBM). HIV-associated PM may progress to IBM. Few literature reports of such patients are available.

Case report and literature review

A 67-year-old African-American woman with HIV and Sjogren’s syndrome was diagnosed with HIV-associated inclusion body myositis with proximal weakness. She had intermediate findings between PM and IBM, including MRI with increased T2 signal and enhancement in proximal leg muscles, and biopsy showing interstitial inflammation, MHC1 upregulation, and rare rimmed sarcoplasmic vacuoles. Initial serum creatine kinase (CK) of 3,407 IU/L downtrended to 265 on high dose prednisone. When steroids were weaned off, she experienced a clinical relapse and increase in CK to 3,705 U/L. When started on IV immunoglobulins and pulse dose IV steroids, her CK decreased to 1,847 U/L with some improvement in strength.

 

A 37-year-old African-American man with HIV presented with two years of progressive gait dysfunction. Initial examination found weakness particularly in finger and wrist flexors with proximal leg weakness resulting in being wheelchair bound. Serum CK was 5,255 U/L. Muscle biopsy had intermediate findings between PM and IBM, with multifocal endomysial inflammation with CD8+ T cells invading into viable myofibers, marked fiber size variation, rare rimmed vacuoles and mildly increased number of COX deficient fibers. With scheduled pulse IV steroids, hand strength improved and he could stand.
HIV-associated inflammatory myopathy has overlap between PM and IBM and shows response to immune therapy when sIBM would not. We provide additional evidence for the use of immune therapy in HIV-associated myopathies. 
Authors/Disclosures
Niyatee Samudra, MD (Stanford)
PRESENTER
Dr. Samudra has nothing to disclose.
Jordan S. Loeb, DO (Lone Star Neurology) Dr. Loeb has nothing to disclose.
Shaida Khan, DO (UT Southwestern Medical Center) Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Group instructor with Real CME.